SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017842
Filing Date
2023-11-07
Accepted
2023-11-07 07:00:33
Documents
77
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lqda-20230930x10q.htm   iXBRL 10-Q 1892142
2 EX-10.1 lqda-20230930xex10d1.htm EX-10.1 43298
3 EX-31.1 lqda-20230930xex31d1.htm EX-31.1 15302
4 EX-31.2 lqda-20230930xex31d2.htm EX-31.2 15303
5 EX-32.1 lqda-20230930xex32d1.htm EX-32.1 7568
6 EX-32.2 lqda-20230930xex32d2.htm EX-32.2 7547
7 GRAPHIC lqda-20230930x10q001.jpg GRAPHIC 631
  Complete submission text file 0001558370-23-017842.txt   7986510

Data Files

Seq Description Document Type Size
8 EX-101.SCH lqda-20230930.xsd EX-101.SCH 68661
9 EX-101.CAL lqda-20230930_cal.xml EX-101.CAL 44633
10 EX-101.DEF lqda-20230930_def.xml EX-101.DEF 218514
11 EX-101.LAB lqda-20230930_lab.xml EX-101.LAB 535702
12 EX-101.PRE lqda-20230930_pre.xml EX-101.PRE 389848
71 EXTRACTED XBRL INSTANCE DOCUMENT lqda-20230930x10q_htm.xml XML 1330797
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39724 | Film No.: 231381488
SIC: 2834 Pharmaceutical Preparations